(19)
(11) EP 0 733 122 A1

(12)

(43) Date of publication:
25.09.1996 Bulletin 1996/39

(21) Application number: 94919252.0

(22) Date of filing: 26.05.1994
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
C07K 14/ 015( . )
C12N 9/ 14( . )
A61K 38/ 00( . )
C07H 21/ 04( . )
C12N 1/ 21( . )
C12P 21/ 02( . )
C12R 1/ 19( . )
(86) International application number:
PCT/US1994/005940
(87) International publication number:
WO 1994/028157 (08.12.1994 Gazette 1994/27)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 26.05.1993 US 19930067236

(71) Applicants:
  • UNITED STATES GOVERNMENT as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Bethesda, MD 20892 (US)
  • GENETIC THERAPY, INC.
    Gaithersburg, MD 20878 (US)

(72) Inventors:
  • KOTIN, Robert
    Rockville, MD 20850 (US)
  • SAFER, Brian
    Silver Spring, MD 20902 (US)

(74) Representative: LOUIS, PÖHLAU, LOHRENTZ & SEGETH 
Postfach 3055
90014 Nürnberg
90014 Nürnberg (DE)

   


(54) FUSION PROTEINS CONTAINING ADENO-ASSOCIATED VIRUS REP PROTEIN AND BACTERIAL PROTEIN